ArticleVaccines2023

Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022).

Salvador Domènech-Montoliu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.